These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34086009)

  • 1. On Patient Safety: A Right to Try, Not Exploit.
    Rickert J
    Clin Orthop Relat Res; 2021 Jul; 479(7):1435-1437. PubMed ID: 34086009
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient advocacy. 'Right to Try' laws bypass FDA for last-ditch treatments.
    Servick K
    Science; 2014 Jun; 344(6190):1329. PubMed ID: 24948714
    [No Abstract]   [Full Text] [Related]  

  • 3. "Right to Try" laws.
    Begg CB; Kim K; Neaton JD
    Clin Trials; 2014 Oct; 11(5):519-20. PubMed ID: 25190026
    [No Abstract]   [Full Text] [Related]  

  • 4. Questions of Safety and Fairness Raised as Right-to-Try Movement Gains Steam.
    Jacob JA
    JAMA; 2015 Aug; 314(8):758-60. PubMed ID: 26244653
    [No Abstract]   [Full Text] [Related]  

  • 5. The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill.
    Tsakopoulos A; Han J; Nodler H; Russo V
    Food Drug Law J; 2015; 70(4):617-41. PubMed ID: 26827394
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs on demand.
    Nature; 2015 Nov; 527(7579):410. PubMed ID: 26607505
    [No Abstract]   [Full Text] [Related]  

  • 7. Experts critical of America's right-to-try drug laws.
    Rubin R
    Lancet; 2015 Oct; 386(10001):1325-6. PubMed ID: 26460764
    [No Abstract]   [Full Text] [Related]  

  • 8. Minnesota's Right to Try law.
    Hermer LD
    Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
    [No Abstract]   [Full Text] [Related]  

  • 9. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
    Bateman-House A; Robertson CT
    JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
    [No Abstract]   [Full Text] [Related]  

  • 10. Right-to-try laws: hope, hype, and unintended consequences.
    Bateman-House A; Kimberly L; Redman B; Dubler N; Caplan A
    Ann Intern Med; 2015 Nov; 163(10):796-7. PubMed ID: 26413841
    [No Abstract]   [Full Text] [Related]  

  • 11. Unproven stem cell therapies: is it my right to try?
    Riva L; Campanozzi L; Vitali M; Ricci G; Tambone V
    Ann Ist Super Sanita; 2019; 55(2):179-185. PubMed ID: 31264641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded access rules pose quandary for drug developers.
    Mack GS
    Nat Biotechnol; 2009 Oct; 27(10):871-2. PubMed ID: 19816423
    [No Abstract]   [Full Text] [Related]  

  • 13. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
    Hoerger M
    Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Currents in contemporary ethics. The implications of expanding access to unapproved drugs.
    Talbott MK
    J Law Med Ethics; 2007; 35(2):316-9. PubMed ID: 17518858
    [No Abstract]   [Full Text] [Related]  

  • 15. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.
    Leonard EW
    J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
    Knoepfler PS
    Adv Drug Deliv Rev; 2015 Mar; 82-83():192-6. PubMed ID: 25489841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fairer way to distribute last-ditch drugs gets real-world trial.
    Reardon S
    Nature; 2016 Jun; 534(7606):160-1. PubMed ID: 27279187
    [No Abstract]   [Full Text] [Related]  

  • 18. What compassionate use means for gene therapies.
    Chapman CR; Moch KI; McFadyen A; Kearns L; Watson T; Furlong P; Bateman-House A
    Nat Biotechnol; 2019 Apr; 37(4):352-355. PubMed ID: 30940936
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
    Finkelstein PE
    AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
    [No Abstract]   [Full Text] [Related]  

  • 20. One Last Shot.
    Berlin J
    Tex Med; 2016 Jul; 112(7):33-8. PubMed ID: 27441422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.